In Australia there a few main players that provide venture capital funding to our progressive biotechnology ventures. Most of these venture capital firms are available conduits for sophisticated investors to access later stage, more proven life sciences companies. Examining the portfolios of these VC firms can provide investors with insights into business that may IPO on this listed market in the future. While there are many general VC firms that have a small allocation to life sciences, below is a list of links to the main Australian biotechnology VC company portfolios.
- Brandon Capital Partners – both local and global life science venture capital firm with more than 50 portfolio companies.
- One Ventures – venture capital firm with a portfolio mix of healthcare and other growth companies.
- KP Rx – investment firm with private and early-stage public healthcare investments.
- TenMile – health technology investment firm owned by Tatterang, private investment group.
- Medical Research Commercialisation Fund